PUBLICATIONS

Abstract

A method for prioritizing risk groups for early SARS-CoV-2 vaccination, by the numbers.


McDonald CJ, Baik SH, Zheng Z, Amos L

MedRxiv 2020:2020.12.18.20248504. https://doi.org/10.1101/2020.12.18.20248504.

Abstract:

Background: Given the limited supply of two COVID-19 vaccines, it will be important to choose which risk groups to prioritize for vaccination in order to get the most health benefits from that supply.

Method: In order to help decide how to get the maximum health yield from this limited supply, we implemented a logistic regression model to predict COVID-19 death risk by age, race, and sex and did the same to predict COVID-19 case risk.

Results: Our predictive model ranked all demographic groups by COVID-19 death risk. It was highly concentrated in some demographic groups, e.g. 85+ year old Black, Non-Hispanic patients suffered 1,953 deaths per 100,000. If we vaccinated the 17 demographic groups at highest COVID-19 death ranked by our logistic model, it would require only 3.7% of the vaccine supply needed to vaccinate all the United States, and yet prevent 47% of COVID-19 deaths. Nursing home residents had a higher COVID-19 death risk at 5,200 deaths/100,000, more than our highest demographic risk group. Risk of prison residents and health care workers (HCW) were lower than that of our demographic groups with the highest risks.We saw much less concentration of COVID-19 case risk in any demographic groups compared to the high concentration of COVID-19 death in some such groups. We should prioritize vaccinations with the goal of reducing deaths, not cases, while the vaccine supply is low.

Conclusion: SARS-CoV-2 vaccines protect against severe COVID-19 infection and thus against COVID-19 death per vaccine studies. Allocating at least some of the early vaccine supplies to high risk demographic groups could maximize lives saved. Our model, and the risk estimate it produced, could help states define their vaccine allocation rules.


McDonald CJ, Baik SH, Zheng Z, Amos L A method for prioritizing risk groups for early SARS-CoV-2 vaccination, by the numbers. 
MedRxiv 2020:2020.12.18.20248504. https://doi.org/10.1101/2020.12.18.20248504.

PMID | PMCID | URL: https://doi.org/10.1101/2020.12.18.20248504